These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy. Alexanian R; Migliore PJ J Lab Clin Med; 1970 Feb; 75(2):225-33. PubMed ID: 5414404 [No Abstract] [Full Text] [Related]
4. [Treatment of myeloma]. Le Chevallier PL Sem Hop; 1971 Jan; 47(4):249-51. PubMed ID: 4322132 [No Abstract] [Full Text] [Related]
5. [Comparative study of the melphalan and of the cyclophosphamide in the treatment of Kahler's disease]. Bontoux D; Chenbit D; Delbarre F Therapeutique; 1971 Jan; 47(1):27-32. PubMed ID: 5572915 [No Abstract] [Full Text] [Related]
7. A historical perspective on milestones in multiple myeloma research. Ribatti D Eur J Haematol; 2018 Mar; 100(3):221-228. PubMed ID: 29194778 [TBL] [Abstract][Full Text] [Related]
8. [150 years of Bence Jones protein. A reliable marker for multiple myeloma]. Carlsson M Lakartidningen; 1994 Nov; 91(44):3993-5. PubMed ID: 7967973 [No Abstract] [Full Text] [Related]
9. [Myeloma : symptoms, diagnosis, treatment]. Piguet H; Borg JY; Monconduit M; Bizet M Rev Prat; 1979 Jan; 29(3):333-6, 339-44, 347-8. PubMed ID: 419356 [No Abstract] [Full Text] [Related]
10. Varied picture of multiple myeloma. Singh A; Singh TP; Datta AK J Indian Med Assoc; 1974 May; 62(10):348-51. PubMed ID: 4430839 [No Abstract] [Full Text] [Related]
11. [2 new cases of initial or secondarily non-excreting plasma cell myelomas]. Prost A; Soulilou JP; Gardais J; Hurez D; Cottin S Rev Rhum Mal Osteoartic; 1973 Feb; 40(2):151-7. PubMed ID: 4574504 [No Abstract] [Full Text] [Related]
15. [Isoelectric point of Bence Jones protein and kidney failure in Bence Jones myeloma]. Iavorkovskiĭ LI; Blumberga IA; Velik LV; Pushkarev IA Klin Med (Mosk); 1984 Apr; 62(4):79-84. PubMed ID: 6737972 [No Abstract] [Full Text] [Related]
16. Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients. Carbone PP; Kellerhouse LE; Gehan EA Am J Med; 1967 Jun; 42(6):937-48. PubMed ID: 6027163 [No Abstract] [Full Text] [Related]
17. [Prognosis of Kahler's disease in patients treated and not treated with alkylating agents (apropos of 45 cases)]. Saporta L; Hugon C; Rondier J; Bontoux D; Delbarre F Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):11-8. PubMed ID: 5079686 [No Abstract] [Full Text] [Related]
18. Melphalan in multiple myeloma. Hoogstraten B; Sheehe PR; Cuttner J; Cooper T; Kyle RA; Oberfield RA; Townsend SR; Harley JB; Hayes DM; Costa G; Holland JF Blood; 1967 Jul; 30(1):74-83. PubMed ID: 6028709 [No Abstract] [Full Text] [Related]
19. [Diagnostic difficulties in multiple myeloma]. Kedracki A; Bem S Przegl Lek; 1971; 28(5):363-5. PubMed ID: 5091792 [No Abstract] [Full Text] [Related]
20. [Familial plasmocytoma in mother and son]. Klingler W; Daweke H Onkologie; 1985 Apr; 8(2):85-7. PubMed ID: 3889757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]